Regulatory
-
Mar 05 2013
Aanjaneya Lifecare Posts Robust Growth, net up by 75% in Q3, Inches Close To Acquisition
Aanjaneya Lifecare Posts Robust Growth, net up by 75% in…
Read more -
Mar 05 2013
Price Control of Medicines are detrimental for India’s Healthcare Growth Story & Drives – Kewal Handa, MD, Pfizer & Wyeth India.
Price Control of Medicines are detrimental for India’s Healthcare Growth…
Read more -
Feb 25 2013
Breather for pharma firms as barcode deadline may be extended
Drug makers want loans to implement tech Drug-makers may get…
Read more -
Feb 23 2013
-
Feb 12 2013
INDIA & NOT CHINA WILL BE THE PREFFERED DESTINATION FOR INVESTMENT & RESEARCH
INDIA & NOT CHINA WILL BE THE PREFFERED DESTINATION FOR…
Read more
